James Myatt

James Myatt

Partner

PGDip, MChem, PhD, MRSC, EPA ,CPA

James is an experienced UK and European patent attorney who specialises in protecting cutting-edge chemistry inventions. Before entering the IP profession, James obtained a PhD in organic synthetic chemistry and worked in pharmaceuticals research for over six years, gaining extensive experience in organic synthesis and drug design.

James helps our clients protect their inventions by providing patentability assessments, preparing patent applications, and managing the prosecution of patent applications through to grant in Europe, the UK and worldwide. Through his work, James has established large international patent portfolios for our clients and has gained extensive knowledge of patent examination procedures around the world. James is also experienced in opposition and appeals proceedings at the EPO.

James uses his expertise in organic chemistry and his research experience to help European and US-based clients protect their inventions in the pharmaceuticals and life sciences fields, for example relating to new chemical entities (small molecules) and to second/further medical uses of known drugs based on new indications, patient genotypes, biomarker screening and new dosage forms. James also handles inventions in pharmaceutical manufacturing processes and novel crystalline forms of APIs, such as multicomponent crystal formulations.

Alongside his work for clients in organic and pharmaceutical chemistry, James has developed an interest and expertise in other fields of chemistry related to environmental sustainability and energy storage, for example sustainable carbon fibre-based products, novel high-performance battery materials, carbon capture processes, water-capture technologies, thermoelectric materials, dielectric heating susceptor polymers and electrochemical processes for the energy efficient production of feedstock chemicals.

SPECIFIC AREAS OF EXPERTISE IN PATENTS:

Adhesive products
Agriscience
Catalysis
Chemical engineering
Clean technology
Cleaning materials
Consumer healthcare
Cosmetic products
Diagnostic methods and tools
Environmental chemistry
Food science
Graphene
Materials science
Medical devices
Medical treatment regimes
Novel active pharmaceutical ingredients (APIs)
Packaging technology
Paints and coatings
Pharmaceuticals
Polymers
Processes for manufacturing chemical products
Speciality chemicals
Surfactants
Textiles

View all people

Thought leadership from James Myatt:

Podcasts Dec242025

Inside Plant-Based Meat Patents: What the latest data tells us about sector innovation

In this episode of the Green Shoots Podcast, Appleyard Lees patent attorneys James Myatt and Jack Braithwaite explore the plant-based meat industry through the lens of patent data.

Articles Feb012024

Insect protein innovation on upward trend, despite 2021 slow down

Inside Green Innovation: Progress Report - Third Edition's data shows general upward trend in insect protein innovation, despite 2021 slow down.

Articles Jan142018

A broad law of equivalence in the UK for chemical subject matter? Actavis v Eli explained

As previously reported, the Supreme Court of the United Kingdom have issued a landmark decision on patent infringement. The headline is that a doctrine of equivalents can now be said to apply in the UK and, moreover, apply to chemical subject matter.